The Amazing Tetralogy of Fallot and Depakote

You will sometimes come across a medical condition that does not sound like one at all. The Tetralogy of Fallot is one example, which sounds more like a play than a congenital (at birth) defect. The term “tetralogy” actually does have its origins in theater, and it refers to a type of marathon production of four works by the same author in Greek theater.

In this instance, however, the term refers to a quadruple whammy of congenital heart problems, specifically: pulmonary infundibular stenosis, overriding aorta, ventricular septal defect, and right ventricular hypertrophy. Add in foramen ovale or atrial septal defect and you have a pentalogy. That is one baby with many problems. However, all these medical conditions have one thing in common: it causes the oxygen levels in the blood to drop. When the body is deprived of the oxygen it needs, bad things happen. An easily recognizable symptom of Tetralogy of Fallot is a bluish cast on a baby’s skin, leading to the familiar term “blue baby.”

There are many factors that may lead to Tetralogy of Fallot, including a genetic predisposition, poor prenatal care, and alcoholism. According to the Williams Kherkher website, it is possible that Depakote may also be a possible cause of this condition. This could be mostly because it is a confirmed teratogenic (causes a disruption in fetal development) agent. Another reason is that millions of women have been prescribed it during their pregnancy to manage migraine headaches and epileptic seizures, believing that it was safe to do so.

While there are no studies specifically looking into the link between Tetralogy of Fallot and Depakote, it would be fairly reasonable to suggest that there may be one. If you believe that your child’s congenital heart condition may be due to Depakote, you may be right. Consult with an experience dangerous drugs law firm in your area to find out more.

Read More

Healthy Habits to Avoid Side Effects of Blood Thinners

Anticoagulants, or blood thinners, are a common drug type for treating certain cardiac medical conditions that can prevent clogging and other blood flow obstructions. While blood thinners are common, medications like Xarelto are known to cause severe bleeding incidents, such as gastrointestinal bleeding, brain hemorrhaging, and serious blood loss.

Bleeding is a known risk of all anticoagulants. However, there are methods to preventing serious bleeding incidents. It is important to be aware of habits that can increase the risk of excessive bleeding and simple ways of decreasing risk.

All medications come with safety warnings to help prevent the patient from putting themselves in dangerous situations. While some blood thinners may not specifically warn against consumption of alcohol, excessive drinking while on blood thinners can interfere with the ability of blood to clot. Similarly, vitamin K is responsible for the clotting of blood and eating vitamin K-rich foods may obstruct the ability of blood thinners to work correctly.

Since blood thinners can cause excessive bleeding from sustained injuries, contact sports are ill-advised while prescribed an anticoagulant. Open wounds from sports related injuries can cause severe blood loss since the blood thinner stops blood from clotting. This warning also coincides with bleeding risks on the job. Some professions like construction work lead to a higher risk of uncontrollable bleeding incidents due to the dangerous nature of the work performed.

Consistent monitoring and communication with a physician is the best form of protecting yourself against the side effects of blood thinners. However, according to the website of the Williams Kherkher Law Firm, some risks are unforeseen, and negligent drug manufacturers may fail to warn their patients of serious side effects medication may cause.

Read More

More than 10,000 Lawsuits Filed against Bayer because of Yaz

After earning the US Food and Drug Administration’s approval for patient use in 2006, Yaz gained immediate popularity due to claims that the drug is safe, effective and provides lots of other benefits. Yaz, a Bayer Healthcare Pharmaceuticals drug, easily became one of the most popular and widely prescribed oral contraceptives in the US (and around the globe). It contained Bayer’s uniquely formulated synthetic progestin known as Drospirenone, which effectively prevented egg cells from evolving, thus averting any possibility of pregnancy. But more than just keeping women from becoming pregnant, Yaz was also marketed as an effective treatment for temperate acne, premenstrual dysphoric disorder (PMDD), and premenstrual syndrome (PMS).

From 2001 to 2013, about 23 Canadian women were reported to have died within months of taking Yaz or Yasmin (another oral contraceptive pill which Bayer released in 2001). Besides these deaths, another 300 cases of adverse events were reported by women who suffered (because of the pills) pulmonary embolism (or blood clots in the lungs), heart attack, cerebral thrombosis (a clotting of blood that prevents blood from being supplied to the brain) or deep vein thrombosis (DVT) or blood clot in the legs.

Yaz was also found to cause other ill effects, including migraine, breast pains, leg pain and queasiness. Bayer’s Drospirenone was also found to be responsible in causing impaired vision, numbness of arms or legs, quickness of breath, and chest ache.

Moves from the FDA, in connection to the reported adverse effects of Yaz, included directions to Bayer, one in 2009, to correct its Yaz advertisement, which assertively stated the drug’s benefits and endorsed it as not necessitating any prescription, while taking lightly the risks to health that it can cause, such as blood clot. The other directive was issued in 2012, wherein the FDA asked Bayer to include in Yaz’s label the greater risk for blood clots in those who would use it.

In 2011 a warning was issued by the US FDA and the British Medical Journal (BMJ), stating the risk of blood clots up to 74 percent in women use would take drugs (such as Yaz) that contained the artificial hormone Drospirenone.

The following year (2012), about 10,000 lawsuits were filed against Bayer; yet, despite these lawsuits and the $1 billion in claims settlement the Bayer paid during the same year, the company maintained its position about Yaz’s safety and never admitted liability.

As of February 2013, the number of individuals who have filed personal injury lawsuits against Bayer has reached 13,600. Substantial information posted on the website of Williams Kherkher states that pharmaceutical firms that manufacture dangerous medications should be held liable for their drug’s adverse effects and should be ready to compensate whoever is proven to have been injured because of the use of their products.

Read More